OxThera Intellectual Property AB
556744-2677ActiveDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
Overview
- 0
- Employees
- ≤1K SEK
- Revenue
- 2007
- Founded
Description
OxThera AB is a privately-held biopharmaceutical company dedicated to developing novel treatment options for rare kidney diseases, primarily Primary Hyperoxaluria (PH). Their core mission is to improve the quality of life and extend the life expectancy of patients suffering from this devastating ult...
Tags
Keywords
Company Information
- Industry
- Övrig verksamhet inom juridik, ekonomi, vetenskap och teknik
- Legal Form
- Aktiebolag
- VAT Number
- SE556744267701
Decision Makers
No decision makers found yet
Similar Companies
20 similar companies in FunnelfeedrBioGaia Pharma AB
0 employeesDeveloping and out-licensing novel biotherapeutic platforms from microbiome research.
ULTRAGENYX EUROPE GMBH
Advancing transformative medicines for rare and ultra-rare genetic diseases globally.
Calliditas Therapeutics AB
20–49 employeesPioneering novel treatments for rare renal and hepatic diseases globally.
Sixera Pharma AB
1–4 employeesSmall biotech developing first treatment for rare Netherton syndrome.
AUTHERA AS
6 employeesDeveloping novel FcRn-targeting biologics for therapeutic applications.
Browse More
OxThera Intellectual Property AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo